Literature DB >> 20671218

Patient and technique survival among a Canadian multicenter nocturnal home hemodialysis cohort.

Robert P Pauly1, Katerina Maximova, Jennifer Coppens, Reem A Asad, Andreas Pierratos, Paul Komenda, Michael Copland, Gihad E Nesrallah, Adeera Levin, Anne Chery, Christopher T Chan.   

Abstract

BACKGROUND AND OBJECTIVES: As a result of improved clinical and quality-of-life outcomes compared with conventional hemodialysis, interest in nocturnal home hemodialysis (NHD) has steadily increased in the past decade; however, little is known about the flow of patients through NHD programs or about patient-specific predictors of mortality or technique failure associated with this modality. This study addressed this gap in knowledge. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study included 247 NHD patients of the Canadian Slow Long nightly ExtEnded dialysis Programs (CAN-SLEEP) cohort from 1994 through 2006 inclusive. The association between program- and patient-specific variables and risk for adverse outcomes was determined using uni- and multivariable Cox regression.
RESULTS: A total of 14.6% of the cohort experienced death or technique failure. Unadjusted 1- and 5-year adverse event-free survival was 95.2 and 80.1%, respectively. Significant predictors of a composite of mortality and technique failure included advanced age (P < 0.001), diabetes (P < 0.001), central venous catheter use (P = 0.01), and inability to perform NHD independently (P = 0.009) and were adjusted for center effect. Weekly frequency of NHD was not predictive. Age and diabetes remained significant with multivariable analysis (hazard ratio 1.07 and 2.64, respectively). Unadjusted 1- and 5-year technique survival was 97.9 and 95.2%, respectively. Only age was a significant predictor of technique failure.
CONCLUSIONS: NHD is associated with excellent adverse event-free survival. This study underscores the importance of modality-specific predictors in the success of home hemodialysis, as well as favorable baseline characteristics such as younger age and the absence of diabetes.

Entities:  

Mesh:

Year:  2010        PMID: 20671218      PMCID: PMC2974382          DOI: 10.2215/CJN.00300110

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  10 in total

1.  Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.

Authors:  Christopher T Chan; John S Floras; Judith A Miller; Robert M A Richardson; Andreas Pierratos
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

2.  The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis.

Authors:  Philip A McFarlane; Ahmed M Bayoumi; Andreas Pierratos; Donald A Redelmeier
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

Review 3.  The International Quotidian Hemodialysis Registry: rationale and challenges.

Authors:  Robert M Lindsay; Shannon Carter; Christian Awaraji; Rita S Suri; Gihad Nesrallah
Journal:  Hemodial Int       Date:  2008-07       Impact factor: 1.812

Review 4.  Utility and limitations of a multicenter nocturnal home hemodialysis cohort.

Authors:  Robert P Pauly; Michael Copland; Paul Komenda; Adeera Levin; Andreas Pierratos; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-01       Impact factor: 8.237

5.  Nocturnal hemodialysis: three-year experience.

Authors:  A Pierratos; M Ouwendyk; R Francoeur; S Vas; D S Raj; A M Ecclestone; V Langos; R Uldall
Journal:  J Am Soc Nephrol       Date:  1998-05       Impact factor: 10.121

6.  Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.

Authors:  Bruce F Culleton; Michael Walsh; Scott W Klarenbach; Garth Mortis; Narine Scott-Douglas; Robert R Quinn; Marcello Tonelli; Sarah Donnelly; Matthias G Friedrich; Andreas Kumar; Houman Mahallati; Brenda R Hemmelgarn; Braden J Manns
Journal:  JAMA       Date:  2007-09-19       Impact factor: 56.272

7.  Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study.

Authors:  Kirsten L Johansen; Rebecca Zhang; Yijian Huang; Shu-Cheng Chen; Christopher R Blagg; Alexander S Goldfarb-Rumyantzev; Chistopher D Hoy; Robert S Lockridge; Brent W Miller; Paul W Eggers; Nancy G Kutner
Journal:  Kidney Int       Date:  2009-08-19       Impact factor: 10.612

8.  Outcomes of a provincial home haemodialysis programme--a two-year experience: establishing benchmarks for programme evaluation.

Authors:  Paul Komenda; Michael Copland; Lee Er; Ognjenka Djurdjev; Adeera Levin
Journal:  Nephrol Dial Transplant       Date:  2008-03-10       Impact factor: 5.992

9.  Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis.

Authors:  Braden J Manns; Michael W Walsh; Bruce F Culleton; Brenda Hemmelgarn; Marcello Tonelli; Melissa Schorr; Scott Klarenbach
Journal:  Kidney Int       Date:  2008-12-24       Impact factor: 10.612

10.  Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients.

Authors:  Robert P Pauly; John S Gill; Caren L Rose; Reem A Asad; Anne Chery; Andreas Pierratos; Christopher T Chan
Journal:  Nephrol Dial Transplant       Date:  2009-07-07       Impact factor: 5.992

  10 in total
  22 in total

1.  Survival with three-times weekly in-center nocturnal versus conventional hemodialysis.

Authors:  Eduardo Lacson; Jianglin Xu; Rita S Suri; Gihad Nesrallah; Robert Lindsay; Amit X Garg; Keith Lester; Norma Ofsthun; Michael Lazarus; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

2.  The Burden of Harm--What Is the Ideal Vascular Access for Home Hemodialysis?

Authors:  Emilie Trinh; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-04       Impact factor: 8.237

3.  Survival and hospitalization for intensive home hemodialysis compared with kidney transplantation.

Authors:  Karthik K Tennankore; S Joseph Kim; Heather J Baer; Christopher T Chan
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

4.  Quality Assurance Audit of Technique Failure and 90-Day Mortality after Program Discharge in a Canadian Home Hemodialysis Program.

Authors:  Nikhil Shah; Frances Reintjes; Mark Courtney; Scott W Klarenbach; Feng Ye; Kara Schick-Makaroff; Kailash Jindal; Robert P Pauly
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-24       Impact factor: 8.237

5.  Temporal Trends and Factors Associated with Home Hemodialysis Technique Survival in Canada.

Authors:  Jeffrey Perl; Yingbo Na; Karthik K Tennankore; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-24       Impact factor: 8.237

Review 6.  Intensive home haemodialysis: benefits and barriers.

Authors:  Karthik K Tennankore; Christopher T Chan; Simon P Curran
Journal:  Nat Rev Nephrol       Date:  2012-07-24       Impact factor: 28.314

7.  Buttonhole versus Stepladder Cannulation for Home Hemodialysis: A Multicenter, Randomized, Pilot Trial.

Authors:  Shih-Han S Huang; Jennifer MacRae; Dana Ross; Rameez Imtiaz; Brittany Hollingsworth; Gihad E Nesrallah; Michael A Copland; Philip A McFarlane; Christopher T Chan; Deborah Zimmerman
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-18       Impact factor: 8.237

Review 8.  How to overcome barriers and establish a successful home HD program.

Authors:  Bessie A Young; Christopher Chan; Christopher Blagg; Robert Lockridge; Thomas Golper; Fred Finkelstein; Rachel Shaffer; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

9.  Clinical outcome of home hemodialysis in patients with previous peritoneal dialysis exposure: evaluation of the integrated home dialysis model.

Authors:  Annie-Claire Nadeau-Fredette; Joanne M Bargman; Christopher T Chan
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

10.  Economic evaluation of frequent home nocturnal hemodialysis based on a randomized controlled trial.

Authors:  Scott Klarenbach; Marcello Tonelli; Robert Pauly; Michael Walsh; Bruce Culleton; Helen So; Brenda Hemmelgarn; Braden Manns
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.